WiSA Technologies Reports Q1 2024 Results
- Expecting total of 8 WiSA E licensing agreements by year-end 2024, up from 5 currently - - First WiSA E-enabled products expected to contribute revenue in 2H 2024 - ...
Stay updated with breaking news from Recent Operating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
- Expecting total of 8 WiSA E licensing agreements by year-end 2024, up from 5 currently - - First WiSA E-enabled products expected to contribute revenue in 2H 2024 - ...
Initiated discussions with FDA regarding accelerated approval pathway for CNM-Au8® for the treatment of ALS with the objective of submitting an NDA in 2024Released long-term data from the open-label extension
Firstquarter revenue totaled$160.6 million, representing an increase of16%year-over-year.Trailing four quarter average Net Dollar Retention Rate was113%at the end of thefirstquarter of fiscal2025as compared to127%at the end offirstquarter of fiscal2024.Firstquarter GAAP
Second quarter revenue totaled $143.2 million, representing an increase of 26% year-over-year.Trailing four quarter average Net Dollar Retention Rate was 124% at the end of the second quarter of...
Second quarter revenue totaled $143.2 million, representing an increase of 26% year-over-year.Trailing four quarter average Net Dollar Retention Rate was...